<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38738103</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>A Case of Anti-Synthetase Syndrome With Anti-Glycyl tRNA Synthetases Antibody Developed After COVID-19.</ArticleTitle><Pagination><StartPage>e58004</StartPage><MedlinePgn>e58004</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e58004</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.58004</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) is a life-threatening respiratory disease characterized by severe acute infection. In some cases, COVID-19 symptoms may persist for a long term, posing a significant social problem. Long-term COVID-19 symptoms resemble those observed in various autoimmune diseases, such as dermatomyositis and polymyositis. In this report, we present the case of a 55-year-old woman who had been experiencing persistent dyspnea on exertion since contracting COVID-19 a month ago and was subsequently diagnosed with anti-synthetase syndrome (ASS). The patient presented with fever, dyspnea, rash, mechanic's hands, and arthritis. Computed tomography imaging revealed findings indicative of interstitial pneumonia. Immunological test results were positive for anti-EJ antibody, leading to a diagnosis of ASS based on Solomon's established criteria. The patient's condition improved following treatment with prednisolone, tacrolimus, and intravenous cyclophosphamide. Pathological findings of transbronchial biopsy revealed nonspecific interstitial pneumonia with organizing pneumonia, leading to speculation that ASS had developed after COVID-19. Given the&#xa0;scarcity of reports on ASS development post COVID-19, we conducted a literature review and compared our present case to previous ones. This report highlights the importance of considering ASS in the differential diagnosis of patients with long-term COVID-19 symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Irie et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Irie</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Toho University Sakura Medical Center, Sakura-shi, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakabayashi</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Toho University Sakura Medical Center, Sakura-shi, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matuzawa</LastName><ForeName>Yasuo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Toho University Sakura Medical Center, Sakura-shi, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiruta</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pathology and Laboratory Medicine, Toho University Sakura Medical Center, Sakura-shi, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaneko</LastName><ForeName>Kaichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Rheumatology, Toho University Sakura Medical Center, Sakura-shi, JPN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aminoacyl-trna synthetases</Keyword><Keyword MajorTopicYN="N">anti-ej antibody</Keyword><Keyword MajorTopicYN="N">anti-synthetase syndrome</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">long-term covid-19</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>13</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38738103</ArticleId><ArticleId IdType="pmc">PMC11087665</ArticleId><ArticleId IdType="doi">10.7759/cureus.58004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>New-onset dermatomyositis following COVID-19: a case report. Shimizu H, Matsumoto H, Sasajima T, et al. Front Immunol. 2022;13:1002329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9637802</ArticleId><ArticleId IdType="pubmed">36353621</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: major findings, mechanisms and recommendations. Davis HE, McCorkell L, Vogel JM, Topol EJ. Nat Rev Microbiol. 2023;21:133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>The diagnosis and treatment of antisynthetase syndrome. Witt LJ, Curran JJ, Strek ME. Clin Pulm Med. 2016;23:218&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5006392</ArticleId><ArticleId IdType="pubmed">27594777</ArticleId></ArticleIdList></Reference><Reference><Citation>Anti-synthetase syndrome occurring after SARS-CoV-2 infection. Bouchard Marmen M, Ellezam B, Fritzler MJ, et al. Scand J Rheumatol. 2022;51:255&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">35138215</ArticleId></ArticleIdList></Reference><Reference><Citation>A case of antisynthetase syndrome initially presented with interstitial lung disease mimicking COVID-19. Elsayed M, Abdelgabar A, Karmani J, Majid M. J Med Cases. 2023;14:25&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9881486</ArticleId><ArticleId IdType="pubmed">36755994</ArticleId></ArticleIdList></Reference><Reference><Citation>A case of antisynthetase syndrome presenting solely with life-threatening interstitial lung disease. Tranah E, MacBrayne A, Bhadauria N, Mukerjee D. Clin Med (Lond) 2023;23:85&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11046532</ArticleId><ArticleId IdType="pubmed">36697016</ArticleId></ArticleIdList></Reference><Reference><Citation>Anti-PL-7 antisynthetase syndrome presenting as COVID-19. Blake T, Noureldin B. Rheumatology (Oxford) 2021;60:0&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953951</ArticleId><ArticleId IdType="pubmed">33547779</ArticleId></ArticleIdList></Reference><Reference><Citation>Myositis-related interstitial lung disease and antisynthetase syndrome. Solomon J, Swigris JJ, Brown KK. J Bras Pneumol. 2011;37:100&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3676869</ArticleId><ArticleId IdType="pubmed">21390438</ArticleId></ArticleIdList></Reference><Reference><Citation>Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles. Saygin D, Kim H, Douglas C, et al. Rheumatology (Oxford) 2023;62:3672&#x2013;3679.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10629785</ArticleId><ArticleId IdType="pubmed">36929923</ArticleId></ArticleIdList></Reference><Reference><Citation>A case of antisynthetase syndrome in the setting of SARS-Cov-2 infection. Pe&#xf1;a C, Kalara N, Velagapudi P. Cureus. 2023;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10277010</ArticleId><ArticleId IdType="pubmed">37337554</ArticleId></ArticleIdList></Reference><Reference><Citation>Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Watanabe K, Handa T, Tanizawa K, et al. Respir Med. 2011;105:1238&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pubmed">21514811</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Myall KJ, Mukherjee B, Castanheira AM, et al. Ann Am Thorac Soc. 2021;18:799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, Xiao SY. Mod Pathol. 2020;33:1007&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156231</ArticleId><ArticleId IdType="pubmed">32291399</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Xu Z, Shi L, Wang Y, et al. Lancet Respir Med. 2020;8:420&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. J Thorac Oncol. 2020;15:700&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128866</ArticleId><ArticleId IdType="pubmed">32114094</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. Sasano H, Hagiwara E, Kitamura H, et al. BMC Pulm Med. 2016;16:168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131426</ArticleId><ArticleId IdType="pubmed">27903248</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China. Wu N, Chen Z, Zha G, et al. J Med Virol. 2024;96:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">38436114</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 triggering autoimmune diseases. Mobasheri L, Nasirpour MH, Masoumi E, Azarnaminy AF, Jafari M, Esmaeili SA. Cytokine. 2022;154:155873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8979824</ArticleId><ArticleId IdType="pubmed">35461172</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity. Jaycox JR, Lucas C, Yildirim I, et al. Nat Commun. 2023;14:1299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9996559</ArticleId><ArticleId IdType="pubmed">36894554</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>